Literature DB >> 30829989

CHARACTERISTICS OF TYPE 3 NEOVASCULARIZATION LESIONS: Focus on the Incidence of Multifocal Lesions and the Distribution of Lesion Location.

Jae Hui Kim1, Young Suk Chang2, Jong Woo Kim1, Chul Gu Kim1, Dong Won Lee1.   

Abstract

PURPOSE: To evaluate the incidence of multifocal lesions and the distribution of lesion location in Type 3 neovascularization.
METHODS: This retrospective, observational study included 148 eyes of 148 patients diagnosed with Type 3 neovascularization. The number of Type 3 neovascularization lesions was counted, and the incidence of multiple lesions in an eye was estimated. In addition, the distance from the fovea to the lesion and the geographic location of the lesion were estimated. Pseudodrusen incidence was compared between eyes with and without multifocal lesions.
RESULTS: In total, 169 Type 3 neovascularization lesions were noted. A single lesion was noted in 130 eyes (87.8%), whereas 2 or 3 multifocal lesions were noted in the remaining 18 eyes (12.2%). The mean distance from the fovea to the lesion was 898.8 ± 324.9 µm. The distribution of lesion locations exhibited a fovea-sparing pattern. No lesions were located within 200 µm of the fovea, 20 lesions (11.8%) were located >200 and ≤500 µm away from the fovea, 89 lesions (52.7%) were located >500 and ≤1,000 µm away from the fovea, and 60 lesions (35.5%) were located >1,000 µm away from the fovea. Pseudodrusen incidence was significantly higher in eyes with multifocal lesions (P = 0.024).
CONCLUSION: Two or more multifocal lesions were noted in 12.2% of eyes with Type 3 neovascularization, and pseudodrusen incidence was higher in eyes with multifocal lesions. In addition, lesion distribution exhibited a fovea-sparing pattern. These characteristics may be associated with the distinct pathophysiology of Type 3 neovascularization.

Entities:  

Mesh:

Year:  2020        PMID: 30829989     DOI: 10.1097/IAE.0000000000002489

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  5 in total

1.  Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration?

Authors:  Bilal Haj Najeeb; Ursula Schmidt-Erfurth
Journal:  Eye (Lond)       Date:  2022-09-29       Impact factor: 4.456

2.  Biometrics, Impact, and Significance of Basal Linear Deposit and Subretinal Drusenoid Deposit in Age-Related Macular Degeneration.

Authors:  Ling Chen; Jeffrey D Messinger; Deepayan Kar; Jacque L Duncan; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-01-04       Impact factor: 4.799

3.  The RAP study, report 4: morphological and topographical characteristics of multifocal macular neovascularization type 3.

Authors:  Bilal Haj Najeeb; Gabor G Deak; Stefan Sacu; Ursula Schmidt-Erfurth; Bianca S Gerendas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-26       Impact factor: 3.117

4.  Spatial Dissociation of Subretinal Drusenoid Deposits and Impaired Scotopic and Mesopic Sensitivity in AMD.

Authors:  Yuhua Zhang; SriniVas R Sadda; David Sarraf; Thomas A Swain; Mark E Clark; Kenneth R Sloan; William E Warriner; Cynthia Owsley; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-02-01       Impact factor: 4.799

5.  Longitudinal Analysis of Structural and Functional Changes in Presence of Reticular Pseudodrusen Associated With Age-Related Macular Degeneration.

Authors:  Marlene Sassmannshausen; Maximilian Pfau; Sarah Thiele; Rolf Fimmers; Julia S Steinberg; Monika Fleckenstein; Frank G Holz; Steffen Schmitz-Valckenberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.